Sunday, February 23, 2014 7:36:16 AM
We know that the Articles of Incorporation exist. They were the first filing made on the Nevada SOS website and you could order a copy today is you wanted one:
Action Type: Articles of Incorporation
Document Number: 20050099288-53 # of Pages: 1
File Date: 04/01/2005 Effective Date:
Initial Stock Value: Par Value Shares: 25
000
000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 25
000.00
https://www.nvsilverflume.gov/businessSearch
For starters, as you can see the Articles are only one page long. They undoubtedly have little to offer in the way of information. The detailed processes, rights and obligations stuff is in the By-Laws, which do not appear in the NV filing.
But that's not the point.
The point is that BOTH documents are represented by the company to be included in the SEC filings. They are required to be included in some form...incorporated in, linked or attached as an exhibit to the Form 10-SB that was filed with the SEC in November of 2006. Indeed they appear on the exhibit list at the end of that filing:
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_10sb.htm
See p. 84
Next, see the Edgar Filing Index page for the filing:
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/0001144204-06-047712-index.htm
Note that all of the exhibits in the actual filing list (4.1 thru 4.3 and 10.1 thru 10.10) appear on the Edgar Filing Index page EXCEPT 3.1 and 3.2....the Articles and By-Laws.
THAT'S BECAUSE THEY WERE NOT FILED.
I know that I asked this:
"I welcome anyone at all to provide a link to NNVC's Articles of Incorporation and By-laws......"
I should have added "especially the By-Laws"...that's where one finds the specifics of the processes that I'm looking for.
Ideally NNVC itself will just file them with the SEC as they they said that they did, but didn't, in November of 2006.
Action Type: Articles of Incorporation
Document Number: 20050099288-53 # of Pages: 1
File Date: 04/01/2005 Effective Date:
Initial Stock Value: Par Value Shares: 25
000
000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 25
000.00
https://www.nvsilverflume.gov/businessSearch
For starters, as you can see the Articles are only one page long. They undoubtedly have little to offer in the way of information. The detailed processes, rights and obligations stuff is in the By-Laws, which do not appear in the NV filing.
But that's not the point.
The point is that BOTH documents are represented by the company to be included in the SEC filings. They are required to be included in some form...incorporated in, linked or attached as an exhibit to the Form 10-SB that was filed with the SEC in November of 2006. Indeed they appear on the exhibit list at the end of that filing:
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_10sb.htm
See p. 84
Next, see the Edgar Filing Index page for the filing:
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/0001144204-06-047712-index.htm
Note that all of the exhibits in the actual filing list (4.1 thru 4.3 and 10.1 thru 10.10) appear on the Edgar Filing Index page EXCEPT 3.1 and 3.2....the Articles and By-Laws.
THAT'S BECAUSE THEY WERE NOT FILED.
I know that I asked this:
"I welcome anyone at all to provide a link to NNVC's Articles of Incorporation and By-laws......"
I should have added "especially the By-Laws"...that's where one finds the specifics of the processes that I'm looking for.
Ideally NNVC itself will just file them with the SEC as they they said that they did, but didn't, in November of 2006.
“I have had a wonderful time but this wasn't it.”
..........Groucho
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
